2025 Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization
Top Cited Papers
Open Access
- 22 February 2026
- journal article
- editorial
- Published by Taylor & Francis in mAbs
- Vol. 18 (1) , 2634216
Abstract
Monoclonal antibodies (mAbs) are among the most successful therapeutic modalities, with over 200 marketed products and nearly 1400 candidates in clinical development.1 While high-affinity binding r...Keywords
Funding Information
- Ginkgo Bioworks, Inc
This publication has 34 references indexed in Scilit:
- Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learningNature Biomedical Engineering, 2023
- Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approachesmAbs, 2023
- Evolutionary-scale prediction of atomic-level protein structure with a language modelScience, 2023
- Developability assessment at early-stage discovery to enable development of antibody-derived therapeuticsAntibody Therapeutics, 2022
- Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequencesProtein Science, 2021
- Evaluating Protein Transfer Learning with TAPE.2019
- Affinity Maturation Enhances Antibody Specificity but Compromises Conformational StabilityCell Reports, 2019
- Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubilityNucleic Acids Research, 2019
- Biophysical properties of the clinical-stage antibody landscapeProceedings of the National Academy of Sciences, 2017
- ANARCI: antigen receptor numbering and receptor classificationBioinformatics, 2015